1. Allergen hybrids – next generation vaccines for Fagales pollen immunotherapy. Issue 3 (March 2014) Authors: Pichler, U.; Hauser, M.; Hofer, H.; Himly, M.; Hoflehner, E.; Steiner, M.; Mutschlechner, S.; Hufnagl, K.; Ebner, C.; Mari, A.; Briza, P.; Bohle, B.; Wiedermann, U.; Ferreira, F.; Wallner, M. Journal: Clinical & experimental allergy Issue: Volume 44:Issue 3(2014:Mar.) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cross‐sectional study on allergic sensitization of Austrian adolescents using molecule‐based IgE profiling. Issue 5 (22nd December 2016) Authors: Stemeseder, T.; Klinglmayr, E.; Moser, S.; Lueftenegger, L.; Lang, R.; Himly, M.; Oostingh, G. J.; Zumbach, J.; Bathke, A. C.; Hawranek, T.; Gadermaier, G. Journal: Allergy Issue: Volume 72:Issue 5(2017:May) Page Start: 754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Differences in the intrinsic immunogenicity and allergenicity of Bet v 1 and related food allergens revealed by site‐directed mutagenesis. Issue 2 (14th November 2013) Authors: Roulias, A.; Pichler, U.; Hauser, M.; Himly, M.; Hofer, H.; Lackner, P.; Ebner, C.; Briza, P.; Bohle, B.; Egger, M.; Wallner, M.; Ferreira, F. Journal: Allergy Issue: Volume 69:Issue 2(2014:Feb.) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Differential activation of dendritic cells by toll‐like receptors causes diverse differentiation of naïve CD4+ T cells from allergic patients. Issue 12 (3rd October 2014) Authors: Deifl, S.; Kitzmüller, C.; Steinberger, P.; Himly, M.; Jahn‐Schmid, B.; Fischer, G. F.; Zlabinger, G. J.; Bohle, B. Journal: Allergy Issue: Volume 69:Issue 12(2014:Dec.) Page Start: 1602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. In vitro immuno-nanotoxicological methods that take pre-existing conditions into account. (September 2021) Authors: Himly, M.; Johnson, L.; Mills-Goodlet, R.; Hasenkopf, I.; Hofer, S.; Hofstaetter, N.; Geppert, M.; Duschl, A. Journal: Toxicology letters Issue: Volume 350(2021)Supplement Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Standardization of allergen products: 2. Detailed characterization of GMP‐produced recombinant Phl p 5.0109 as European Pharmacopoeia reference standard. Issue 4 (26th January 2016) Authors: Himly, M.; Nandy, A.; Kahlert, H.; Thilker, M.; Steiner, M.; Briza, P.; Neubauer, A.; Klysner, S.; van Ree, R.; Buchheit, K.‐H.; Vieths, S.; Ferreira, F. Journal: Allergy Issue: Volume 71:Issue 4(2016:Apr.) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗